BMC Pulmonary Medicine, ISSN 1471-2466, 03/2019, Volume 19, Issue 1, pp. 66 - 7
BackgroundCorticosteroids are widely used to control asthma symptoms, but steroid resistance (SR) is a common adverse reaction. Therefore, it is important to...
OX40 ligand (OX40L) | Biomarker | Steroid resistance (SR) | Inhaled corticosteroids (ICS) | Asthma | IL-6 | THYMIC STROMAL LYMPHOPOIETIN | MURINE MODEL | OX40/OX40L | THERAPY | RESPIRATORY SYSTEM | INFLAMMATION | EXPRESSION | T-CELLS | Multivariate Analysis | Neutrophils - cytology | Predictive Value of Tests | Forced Expiratory Volume - drug effects | Monocytes - cytology | Humans | Administration, Inhalation | Adrenal Cortex Hormones - pharmacology | Child, Preschool | Logistic Models | Male | Biomarkers - blood | Asthma - drug therapy | Case-Control Studies | Interleukin-6 - blood | Asthma - blood | Female | ROC Curve | OX40 Ligand - blood | Child | Drug Resistance | Cytokines - blood | Pediatrics | Medical research | Enzymes | Care and treatment | Corticosteroids | Asthma in children | Immunoglobulin E | B cells | Interleukins | Analysis | Medicine, Experimental | Health aspects | Enzyme-linked immunosorbent assay
OX40 ligand (OX40L) | Biomarker | Steroid resistance (SR) | Inhaled corticosteroids (ICS) | Asthma | IL-6 | THYMIC STROMAL LYMPHOPOIETIN | MURINE MODEL | OX40/OX40L | THERAPY | RESPIRATORY SYSTEM | INFLAMMATION | EXPRESSION | T-CELLS | Multivariate Analysis | Neutrophils - cytology | Predictive Value of Tests | Forced Expiratory Volume - drug effects | Monocytes - cytology | Humans | Administration, Inhalation | Adrenal Cortex Hormones - pharmacology | Child, Preschool | Logistic Models | Male | Biomarkers - blood | Asthma - drug therapy | Case-Control Studies | Interleukin-6 - blood | Asthma - blood | Female | ROC Curve | OX40 Ligand - blood | Child | Drug Resistance | Cytokines - blood | Pediatrics | Medical research | Enzymes | Care and treatment | Corticosteroids | Asthma in children | Immunoglobulin E | B cells | Interleukins | Analysis | Medicine, Experimental | Health aspects | Enzyme-linked immunosorbent assay
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 8912 - 19
Asthma is a chronic inflammatory disorder of the airways. Disease presentation varies greatly in terms of cause, development, severity, and response to...
GLOBAL BURDEN | NATURAL-KILLER-CELLS | HOSPITAL ADMISSIONS | EXPRESSION ANALYSIS | MULTIDISCIPLINARY SCIENCES | REGULATORY T-CELLS | INHALED CORTICOSTEROIDS | AIRWAY INFLAMMATION | RESPIRATORY HEALTH | GENDER-DIFFERENCES | TOLL-LIKE RECEPTOR-1 | Phenotypes | rRNA 16S | Granulocyte-macrophage colony-stimulating factor | Hypersensitivity | MiRNA | Microbiomes | Immunoglobulin E | Tumor necrosis factor-α | Gene expression | Eotaxin | Atopy | Asthma | Interleukin 4 | Monocyte chemoattractant protein 1
GLOBAL BURDEN | NATURAL-KILLER-CELLS | HOSPITAL ADMISSIONS | EXPRESSION ANALYSIS | MULTIDISCIPLINARY SCIENCES | REGULATORY T-CELLS | INHALED CORTICOSTEROIDS | AIRWAY INFLAMMATION | RESPIRATORY HEALTH | GENDER-DIFFERENCES | TOLL-LIKE RECEPTOR-1 | Phenotypes | rRNA 16S | Granulocyte-macrophage colony-stimulating factor | Hypersensitivity | MiRNA | Microbiomes | Immunoglobulin E | Tumor necrosis factor-α | Gene expression | Eotaxin | Atopy | Asthma | Interleukin 4 | Monocyte chemoattractant protein 1
Journal Article
CURRENT DRUG TARGETS, ISSN 1389-4501, 2019, Volume 20, Issue 16, pp. 1670 - 1679
Introduction: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019 recommends the use of absolute blood eosinophil count as a guide for the...
OBSTRUCTIVE PULMONARY-DISEASE | exacerbations | STABILITY | ASTHMA | RISK | PHARMACOLOGY & PHARMACY | Chronic obstructive pulmonary disease | eosinophil | POST-HOC ANALYSIS | blood eosinophils | pharmacological | inhaled corticosteroids | Corticoids | Respiratory therapy | Therapy | Corticosteroids | Thresholds | Lung diseases | Clinical trials | Risk | Systematic review | Disease control | Blood | Asthma | Obstructive lung disease
OBSTRUCTIVE PULMONARY-DISEASE | exacerbations | STABILITY | ASTHMA | RISK | PHARMACOLOGY & PHARMACY | Chronic obstructive pulmonary disease | eosinophil | POST-HOC ANALYSIS | blood eosinophils | pharmacological | inhaled corticosteroids | Corticoids | Respiratory therapy | Therapy | Corticosteroids | Thresholds | Lung diseases | Clinical trials | Risk | Systematic review | Disease control | Blood | Asthma | Obstructive lung disease
Journal Article
BMC PEDIATRICS, 11/2019, Volume 19, Issue 1, pp. 1 - 6
Background: Inhaled corticosteroids (ICS) are the most effective treatment for children with persistent asthma. However adverse effects of ICS on Hypothalamo...
Vitamin D | Growth | INSUFFICIENCY | BUDESONIDE | PEDIATRICS | Inhaled corticosteroids | HEIGHT | Bone metabolism | Adrenal suppression | Asthma
Vitamin D | Growth | INSUFFICIENCY | BUDESONIDE | PEDIATRICS | Inhaled corticosteroids | HEIGHT | Bone metabolism | Adrenal suppression | Asthma
Journal Article
Equine Veterinary Journal, ISSN 0425-1644, 11/2019, Volume 51, Issue 6, pp. 779 - 786
Summary Background Inhaled corticosteroids are effective for the treatment of equine asthma but they induce cortisol suppression with potential side effects....
horse | inhalation therapy | RAO | cortisol | lung function | inhaled corticosteroids
horse | inhalation therapy | RAO | cortisol | lung function | inhaled corticosteroids
Journal Article
Turkish Thoracic Journal, ISSN 2148-7197, 04/2019, Volume 20, Issue 2, pp. 136 - 139
Worldwide, asthma is a major health problem and inhaled corticosteroids (ICS) are the mainstay of asthma treatment. High-dose and long-term use of ICS can...
Side effects | Inhaled corticosteroids | Oropharyngeal candidiasis | Asthma treatment | Asthma | asthma treatment | side effects | asthma | Original | inhaled corticosteroids
Side effects | Inhaled corticosteroids | Oropharyngeal candidiasis | Asthma treatment | Asthma | asthma treatment | side effects | asthma | Original | inhaled corticosteroids
Journal Article
Pediatric Pulmonology, ISSN 8755-6863, 10/2019, Volume 54, Issue 10, pp. 1567 - 1577
Background Recurrent asthma‐like symptoms are common in infants, but few population studies describe diagnostic and treatment practice. Methods Using the...
health care utilization | infants | preventive therapy | controller treatment | leukotriene receptor antagonists | asthma | infantile asthma | wheezing | inhaled corticosteroids | MONTELUKAST | EFFICACY | LUNG-FUNCTION | INHALED FLUTICASONE PROPIONATE | CHILDHOOD ASTHMA | PRESCHOOL-CHILDREN | RESPIRATORY SYSTEM | DOUBLE-BLIND | PEDIATRICS | 1ST 6 YEARS | CORTICOSTEROIDS | YOUNG-CHILDREN
health care utilization | infants | preventive therapy | controller treatment | leukotriene receptor antagonists | asthma | infantile asthma | wheezing | inhaled corticosteroids | MONTELUKAST | EFFICACY | LUNG-FUNCTION | INHALED FLUTICASONE PROPIONATE | CHILDHOOD ASTHMA | PRESCHOOL-CHILDREN | RESPIRATORY SYSTEM | DOUBLE-BLIND | PEDIATRICS | 1ST 6 YEARS | CORTICOSTEROIDS | YOUNG-CHILDREN
Journal Article
EXPERIMENTAL AND THERAPEUTIC MEDICINE, ISSN 1792-0981, 10/2019, Volume 18, Issue 4, pp. 2893 - 2900
Short-term efficacy and safety of prednisone in herpes zoster and the effect on IL-6 and IL-10 were investigated. A total of 125 patients (aged 40-70 years)...
MEDICINE, RESEARCH & EXPERIMENTAL | therapeutic effect | PLACEBO | herpes zoster | PAIN | INHALED CORTICOSTEROIDS | METHOTREXATE | RISK | prednisone | IL-6 | IL-10
MEDICINE, RESEARCH & EXPERIMENTAL | therapeutic effect | PLACEBO | herpes zoster | PAIN | INHALED CORTICOSTEROIDS | METHOTREXATE | RISK | prednisone | IL-6 | IL-10
Journal Article
Expert Review of Clinical Immunology, ISSN 1744-666X, 09/2019, Volume 15, Issue 9, pp. 951 - 958
Introduction: The precision medicine approach that is now mandatory for severe asthma management includes the use of novel biologic agents blocking specific...
real-life studies | precision medicine | clinical trials | biologics | Asthma | OMALIZUMAB | PLACEBO | MEPOLIZUMAB | INHALED CORTICOSTEROIDS | PERSISTENT ASTHMA | SEVERE ALLERGIC-ASTHMA | MONOCLONAL-ANTIBODY | IMMUNOLOGY | DUPILUMAB | DOUBLE-BLIND | ANTI-IGE ANTIBODY
real-life studies | precision medicine | clinical trials | biologics | Asthma | OMALIZUMAB | PLACEBO | MEPOLIZUMAB | INHALED CORTICOSTEROIDS | PERSISTENT ASTHMA | SEVERE ALLERGIC-ASTHMA | MONOCLONAL-ANTIBODY | IMMUNOLOGY | DUPILUMAB | DOUBLE-BLIND | ANTI-IGE ANTIBODY
Journal Article
Disease-a-Month, ISSN 0011-5029, 09/2019, p. 100886
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 07/2019, Volume 20, Issue 11, pp. 1397 - 1404
Introduction: Sarcoidosis is a granulomatous systemic disease of unknown cause where the lungs are the most frequently affected. Therapeutic management of the...
Glucocorticoids | Immunosuppressive Therapy | Pulmonary Sarcoidosis | FIBROSIS | MAINTENANCE TREATMENT | MANAGEMENT | PROGNOSIS | METHOTREXATE | INHALED BUDESONIDE | CORTICOSTEROID-THERAPY | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HYPERTENSION | LEFLUNOMIDE
Glucocorticoids | Immunosuppressive Therapy | Pulmonary Sarcoidosis | FIBROSIS | MAINTENANCE TREATMENT | MANAGEMENT | PROGNOSIS | METHOTREXATE | INHALED BUDESONIDE | CORTICOSTEROID-THERAPY | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HYPERTENSION | LEFLUNOMIDE
Journal Article
PEDIATRIC DRUGS, ISSN 1174-5878, 08/2019, Volume 21, Issue 4, pp. 215 - 237
Severe asthma in children remains a significant issue. It places a heavy burden on affected individuals and society as a whole in terms of high morbidity,...
OMALIZUMAB | MEPOLIZUMAB | SEVERE EOSINOPHILIC ASTHMA | EFFICACY | LONG-TERM SAFETY | ALLERGIC-ASTHMA | DOUBLE-BLIND | INHALED CORTICOSTEROIDS | PERSISTENT ASTHMA | PEDIATRICS | PHARMACOLOGY & PHARMACY | ANTI-IGE
OMALIZUMAB | MEPOLIZUMAB | SEVERE EOSINOPHILIC ASTHMA | EFFICACY | LONG-TERM SAFETY | ALLERGIC-ASTHMA | DOUBLE-BLIND | INHALED CORTICOSTEROIDS | PERSISTENT ASTHMA | PEDIATRICS | PHARMACOLOGY & PHARMACY | ANTI-IGE
Journal Article
Annals of Allergy, Asthma & Immunology, ISSN 1081-1206, 08/2019, Volume 123, Issue 2, pp. 193 - 200
Despite potential value of identification of allergic inflammation with fractional exhaled nitric oxide (FeNO) in managing asthma, randomized clinical trials...
MANAGEMENT | PREDICTOR | ALLERGY | ADOLESCENTS | INHALED CORTICOSTEROIDS | AIRWAY INFLAMMATION | LUNG-FUNCTION | ADULTS | NATIONAL-HEALTH | IMMUNOLOGY | CHILDREN
MANAGEMENT | PREDICTOR | ALLERGY | ADOLESCENTS | INHALED CORTICOSTEROIDS | AIRWAY INFLAMMATION | LUNG-FUNCTION | ADULTS | NATIONAL-HEALTH | IMMUNOLOGY | CHILDREN
Journal Article
The Journal of Allergy and Clinical Immunology: In Practice, ISSN 2213-2198, 07/2019, Volume 7, Issue 6, pp. 1740 - 1747
Eosinophilic airway inflammation is observed in 30% to 50% of chronic cough sufferers. It is a common feature of asthma and upper airway cough syndrome, and it...
Feno | Chronic rhinosinusitis | Chronic cough | Rhinitis | Nonasthmatic eosinophilic bronchitis | Mast cell | Upper airway cough syndrome | Eosinophil | Asthma | FENO | BRONCHITIS | ADD-ON MONTELUKAST | MANAGEMENT | VARIANT ASTHMA | IMMUNOLOGY | CHRONIC AIRWAY-OBSTRUCTION | INHALED BUDESONIDE | ALLERGY | INDUCED SPUTUM | NONALLERGIC RHINITIS | EXHALED NITRIC-OXIDE | CHEST GUIDELINE | Corticoids | Cytokines | Rhinosinusitis | Leukocytes (eosinophilic) | Smooth muscle | Inflammation | Eosinophilia | Polyposis | Cough | Allergies | Respiratory tract | Allergic rhinitis | Medical education | Biomarkers | Respiratory tract diseases | Bronchitis | Accreditation | Diagnosis | Chemokines
Feno | Chronic rhinosinusitis | Chronic cough | Rhinitis | Nonasthmatic eosinophilic bronchitis | Mast cell | Upper airway cough syndrome | Eosinophil | Asthma | FENO | BRONCHITIS | ADD-ON MONTELUKAST | MANAGEMENT | VARIANT ASTHMA | IMMUNOLOGY | CHRONIC AIRWAY-OBSTRUCTION | INHALED BUDESONIDE | ALLERGY | INDUCED SPUTUM | NONALLERGIC RHINITIS | EXHALED NITRIC-OXIDE | CHEST GUIDELINE | Corticoids | Cytokines | Rhinosinusitis | Leukocytes (eosinophilic) | Smooth muscle | Inflammation | Eosinophilia | Polyposis | Cough | Allergies | Respiratory tract | Allergic rhinitis | Medical education | Biomarkers | Respiratory tract diseases | Bronchitis | Accreditation | Diagnosis | Chemokines
Journal Article
Allergy, ISSN 0105-4538, 07/2019, Volume 74, Issue 7, pp. 1249 - 1256
Chronic obstructive pulmonary disease (COPD) is a major global health problem that is poorly treated by current therapies as it has proved difficult to treat...
asthma‐COPD overlap | macrophage | eosinophil | neutrophil | exacerbations | interleukin‐5 | asthma-COPD overlap | interleukin-5 | GLOBAL BURDEN | SMALL-AIRWAY-OBSTRUCTION | BLOOD EOSINOPHIL COUNT | INHALED CORTICOSTEROIDS | IMMUNOLOGY | CCR5 CHEMOKINES | OBSTRUCTIVE PULMONARY-DISEASE | ALLERGY | SPUTUM EOSINOPHILIA | OVERLAP SYNDROME | ALPHA-1-ANTITRYPSIN DEFICIENCY | POST-HOC ANALYSIS | Interleukins | Lung diseases, Obstructive | Corticoids | Corticosteroids | Secretion | Leukocytes (eosinophilic) | Lung diseases | Leukocytes (neutrophilic) | Inflammation | Macrophages | Eosinophilia | Patients | Blood | Asthma | Heterogeneity | Monocytes | Lungs | Obstructive lung disease | Sputum | Chronic obstructive pulmonary disease | Public health | Eosinophils
asthma‐COPD overlap | macrophage | eosinophil | neutrophil | exacerbations | interleukin‐5 | asthma-COPD overlap | interleukin-5 | GLOBAL BURDEN | SMALL-AIRWAY-OBSTRUCTION | BLOOD EOSINOPHIL COUNT | INHALED CORTICOSTEROIDS | IMMUNOLOGY | CCR5 CHEMOKINES | OBSTRUCTIVE PULMONARY-DISEASE | ALLERGY | SPUTUM EOSINOPHILIA | OVERLAP SYNDROME | ALPHA-1-ANTITRYPSIN DEFICIENCY | POST-HOC ANALYSIS | Interleukins | Lung diseases, Obstructive | Corticoids | Corticosteroids | Secretion | Leukocytes (eosinophilic) | Lung diseases | Leukocytes (neutrophilic) | Inflammation | Macrophages | Eosinophilia | Patients | Blood | Asthma | Heterogeneity | Monocytes | Lungs | Obstructive lung disease | Sputum | Chronic obstructive pulmonary disease | Public health | Eosinophils
Journal Article
16.
Full Text
Inhaled corticosteroid therapy in adult asthma time for a new therapeutic dose terminology
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 06/2019, Volume 199, Issue 12, pp. 1471 - 1477
The Global Initiative for Asthma guidelines use the traditional terminology of "low," "medium," and "high" doses of inhaled corticosteroids (ICS) to define...
Inhaled corticosteroids | Dose–response relationship | Asthma | RESPONSIVENESS | SAFETY | BUDESONIDE | asthma | RESPONSE RELATIONSHIP | COMBINATION | HYPERRESPONSIVENESS | FUROATE | FLUTICASONE PROPIONATE | RESPIRATORY SYSTEM | EXACERBATIONS | dose-response relationship | EXHALED NITRIC-OXIDE | inhaled corticosteroids | CRITICAL CARE MEDICINE | Clinical trials | Jargon | Systematic review | Thorax | Adults | Teenagers | Diabetes | Drug dosages | Meta-analysis
Inhaled corticosteroids | Dose–response relationship | Asthma | RESPONSIVENESS | SAFETY | BUDESONIDE | asthma | RESPONSE RELATIONSHIP | COMBINATION | HYPERRESPONSIVENESS | FUROATE | FLUTICASONE PROPIONATE | RESPIRATORY SYSTEM | EXACERBATIONS | dose-response relationship | EXHALED NITRIC-OXIDE | inhaled corticosteroids | CRITICAL CARE MEDICINE | Clinical trials | Jargon | Systematic review | Thorax | Adults | Teenagers | Diabetes | Drug dosages | Meta-analysis
Journal Article
Infection, ISSN 0300-8126, 6/2019, Volume 47, Issue 3, pp. 377 - 385
Recent studies have suggested a possible association between respiratory infection and the use of inhaled corticosteroids (ICS). We aimed to ascertain the risk...
Upper respiratory tract infection (URTI) | Medicine & Public Health | Inhaled corticosteroids (ICS) | General Practice / Family Medicine | Infectious Diseases | Internal Medicine | Risk | Asthma | Meta-analysis | Corticoids | Respiratory therapy | Budesonide | Corticosteroids | Health risks | Clinical trials | Infections | Fluticasone | Patients | Subgroups | Scientific papers | Respiratory tract | Heterogeneity | Search engines | Respiratory tract diseases | Steroids
Upper respiratory tract infection (URTI) | Medicine & Public Health | Inhaled corticosteroids (ICS) | General Practice / Family Medicine | Infectious Diseases | Internal Medicine | Risk | Asthma | Meta-analysis | Corticoids | Respiratory therapy | Budesonide | Corticosteroids | Health risks | Clinical trials | Infections | Fluticasone | Patients | Subgroups | Scientific papers | Respiratory tract | Heterogeneity | Search engines | Respiratory tract diseases | Steroids
Journal Article
Pediatric Research, ISSN 0031-3998, 04/2019, Volume 85, Issue 5, pp. 625 - 633
BACKGROUND: Bronchopulmonary dysplasia (BPD) is an orphan disease and advances in prevention and treatment are lacking. The clinical efficacy of systemic...
CONTROLLED-TRIAL | SEVERITY SCORE | IMPROVED LUNG-FUNCTION | BIRTH-WEIGHT INFANTS | SURFACTANT | VENTILATOR-DEPENDENT INFANTS | MECHANICAL VENTILATION | PEDIATRICS | POLYMORPHISM | LOW-DOSE DEXAMETHASONE | INHALED NITRIC-OXIDE
CONTROLLED-TRIAL | SEVERITY SCORE | IMPROVED LUNG-FUNCTION | BIRTH-WEIGHT INFANTS | SURFACTANT | VENTILATOR-DEPENDENT INFANTS | MECHANICAL VENTILATION | PEDIATRICS | POLYMORPHISM | LOW-DOSE DEXAMETHASONE | INHALED NITRIC-OXIDE
Journal Article
Allergology International, ISSN 1323-8930, 04/2019, Volume 68, Issue 2, pp. 150 - 157
Severe asthma in children is associated with significant morbidity. Children with severe asthma are at increased risk for adverse outcomes including...
Difficult to treat asthma | Pediatric severe asthma | Asthma evaluation | Asthma management | Severe asthma evaluation | BLOOD EOSINOPHIL COUNTS | INHA
Difficult to treat asthma | Pediatric severe asthma | Asthma evaluation | Asthma management | Severe asthma evaluation | BLOOD EOSINOPHIL COUNTS | INHA